Literature DB >> 2881023

Prophylaxis of first variceal hemorrhage in patients with liver cirrhosis.

T Sauerbruch, G Kleber, A Gerbes, G Paumgartner.   

Abstract

Prophylaxis of bleeding from esophageal varices is a very tempting concept at first glance, especially under the assumption of a high mortality associated with first variceal hemorrhage. Up to now four different measures have been tried for prophylaxis: portacaval shunt operation, devascularization procedures, sclerotherapy, and drugs. With the exception of portacaval shunts, ongoing controlled trials show a weak trend toward reduction of variceal bleeding and prolongation of survival in selected patients with compensated cirrhosis and large varices. However, prophylaxis of first variceal bleeding must still be regarded as experimental and should be restricted to controlled clinical studies.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2881023     DOI: 10.1007/bf01785707

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  76 in total

1.  Correlation between the severity of esophageal varices in portal cirrhosis and their propensity toward hemorrhage.

Authors:  E D PALMER; I B BRICK
Journal:  Gastroenterology       Date:  1956-01       Impact factor: 22.682

2.  Portal venous-esophageal luminal pressure gradient in cirrhosis.

Authors:  P Reding; D Urbain; A Grivegnee; D Frere
Journal:  Hepatology       Date:  1986 Jan-Feb       Impact factor: 17.425

Review 3.  Nadolol: a new beta-adrenoceptor antagonist.

Authors:  W H Frishman
Journal:  N Engl J Med       Date:  1981-09-17       Impact factor: 91.245

4.  [Relationship between portal hypertension, ascites, gastro-esophageal varices, and gastrointestinal bleeding in patients with alcoholic cirrhosis (author's transl)].

Authors:  M Doffoel; C M Brandt; J L Fincker; R Bockel
Journal:  Gastroenterol Clin Biol       Date:  1980-05

5.  Hemodynamic evaluation of patients with intrahepatic portal hypertension. Relationship between bleeding varices and the portohepatic gradient.

Authors:  A Viallet; D Marleau; M Huet; F Martin; A Farley; J P Villeneuve; P Lavoie
Journal:  Gastroenterology       Date:  1975-12       Impact factor: 22.682

Review 6.  [Pharmacological therapy of portal hypertension].

Authors:  T Miotti; J Reichen
Journal:  Schweiz Med Wochenschr       Date:  1985-10-19

7.  Histologic factors of the esophageal transection ring as clues to the pathogenesis of bleeding varices.

Authors:  R A Spence; J M Sloan; G W Johnston
Journal:  Surg Gynecol Obstet       Date:  1984-09

8.  Clinical and prognostic significance of portohepatic gradient in patients with cirrhosis.

Authors:  J P Vinel; J Cassigneul; A Louis; M Levade; J P Pascal
Journal:  Surg Gynecol Obstet       Date:  1982-09

9.  Intravascular oesophageal variceal pressure (IOVP) assessed by endoscopic fine needle puncture under basal conditions, Valsalva's manoeuvre and after glyceryltrinitrate application.

Authors:  M Staritz; T Poralla; K H Meyer zum Büschenfelde
Journal:  Gut       Date:  1985-05       Impact factor: 23.059

10.  Effect of selective blockade of beta 2-adrenergic receptors on portal and systemic hemodynamics in a portal hypertensive rat model.

Authors:  R J Kroeger; R J Groszmann
Journal:  Gastroenterology       Date:  1985-04       Impact factor: 22.682

View more
  1 in total

1.  Prophylactic endoscopic sclerotherapy of oesophageal varices in liver cirrhosis. A multicentre prospective controlled randomised trial in Vienna.

Authors:  R Pötzi; P Bauer; W Reichel; E Kerstan; F Renner; A Gangl
Journal:  Gut       Date:  1989-06       Impact factor: 23.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.